Delirium, catatonía y síndrome de abstinencia manifestados como agitación psicomotora en COVID-19: una propuesta de manejo farmacológico en el hospital general
Rev. méd. Chile
;
150(3)mar. 2022.
Article
in Spanish
|
LILACS-Express
| LILACS
| ID: biblio-1409809
ABSTRACT
Background:
Neuropsychiatric symptoms can be part of the clinical spectrum of COVID-19 infections.Aim:
To devise an evidence based clinical algorithm as a guide for clinicians, to identify and treat underlying clinical syndromes of psychomotor agitation, such as delirium, catatonia or substance withdrawal in patients who are hospitalized and infected with SARS-CoV-2. Material andMethods:
A review of the literature about the pharmacological management of neuropsychiatric manifestations of COVID-19 at the general hospital, to develop a clinical protocol based on a consensus from an interdisciplinary expert panel at a Clinical Hospital.Results:
A consensual clinical algorithm for the management of delirium, catatonia, and substance withdrawal, manifested as psychomotor agitation in patients hospitalized with COVID-19, was developed as a clinical proposal for physicians at different levels of complexity in health services.Conclusions:
Cooperation among different clinical units in the general hospital facilitated the implementation of a clinical algorithm for clinicians for the management of psychomotor agitation in COVID-19 patients.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Practice guideline
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS